New telehealth program aims to ease daily struggles for advanced cancer patients
NCT ID NCT06555588
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a telehealth program called ENGAGE for people with stage IV breast, prostate, lung, or colorectal cancer. The program helps manage symptoms like pain, fatigue, and distress that interfere with daily life. About 190 participants will be randomly assigned to ENGAGE or standard supportive care, and their progress will be tracked over 4 months. The goal is to see if this approach improves how patients feel and function.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Duke Cancer Network
RECRUITINGDurham, North Carolina, 27713, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Step drug combo outsmart advanced HER2-Positive breast cancer?
- Can a new injection tame prostate cancer by cutting testosterone?
- Can a drug cocktail cure metastatic breast cancer? a trial aims to find out
- Can a pill combo outpace chemotherapy for aggressive breast cancer?
- Can a pill boost the immune system to fight Hard-to-Treat cancers?
- Can a new drug combo shrink Hard-to-Treat colorectal tumors?